Ibrahim Zeinab A, El-Ashmawy Amal A, Shora Ola A
Department of Dermatology & Venereology, Faculty of Medicine, Tanta University, Tanta, Egypt.
Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
J Cosmet Dermatol. 2017 Sep;16(3):388-399. doi: 10.1111/jocd.12356. Epub 2017 May 14.
New treatments and techniques were being added over the last few years to treat atrophic scars with variable results and adverse effects.
The aim of this study was to evaluate and compare the therapeutic efficacy and safety of microneedling, autologous platelet-rich plasma, and combination of both procedures in the treatment of atrophic scars.
This study included 90 patients with atrophic scars and were classified randomly into three groups: I: 28 patients treated with microneedling, one session every 4 weeks; II: 34 patients treated with intradermal injection of platelet-rich plasma, one session every 2 weeks; and III: 28 patients treated with alternative sessions of each microneedling and platelet-rich plasma, 2 weeks between each session, for a maximum of six sessions.
There was a statistically significant improvement in the appearance of atrophic scars, with reduction in the scores associated with the clinical evaluation scale for atrophic scarring in all groups, but the improvement was more obvious in group III.
Although a single treatment may give good results, combination between skin needling and platelet-rich plasma is more effective, safe with less number of sessions in all types of atrophic scars.
在过去几年中,不断有新的治疗方法和技术被用于治疗萎缩性瘢痕,但其效果和不良反应各不相同。
本研究旨在评估和比较微针治疗、自体富血小板血浆以及两者联合治疗萎缩性瘢痕的疗效和安全性。
本研究纳入了90例萎缩性瘢痕患者,随机分为三组:I组:28例患者接受微针治疗,每4周进行一次;II组:34例患者接受皮内注射富血小板血浆治疗,每2周进行一次;III组:28例患者接受微针和富血小板血浆交替治疗,每次治疗间隔2周,最多进行6次。
萎缩性瘢痕的外观有统计学意义上的显著改善,所有组与萎缩性瘢痕临床评估量表相关的评分均降低,但III组的改善更为明显。
虽然单一治疗可能会取得良好效果,但皮肤微针和富血小板血浆联合治疗在各类萎缩性瘢痕中更有效、更安全,且治疗次数更少。